In cancer, POLR2A is frequently overexpressed across tumor types, including breast (Xu et al., 2019), lung (Zeng et al., 2021), colon carcinomas (Liu et al., 2015), and glioblastomas (Wei et al., 2019). Here, POLR2A is linked to neoplasm.